Cosmetic notification is the step that most often derails a launch calendar, and since the United Kingdom left the European Union it is also the step that brands most often get wrong. A product notified in the EU is not notified in Great Britain, and a product notified in Great Britain is not notified in the EU. The two systems look similar, use similar information, and are legally separate.
The practical consequence is a second notification, a second responsible person and, in many cases, a second set of artwork changes for the responsible person address. Brands that build this into the plan at the start absorb it easily. Brands that discover it three weeks before launch usually delay.
This guide is written for brand owners and sourcing managers preparing a cosmetic for the European and UK markets. It covers who is responsible for each notification, what information each system requires, how Great Britain and Northern Ireland differ, and the documentation that has to exist before any notification is filed.
Notification requirements and portal processes change, and the differences between Great Britain and Northern Ireland have been subject to political agreement rather than to fixed technical rules. Confirm the current position with the relevant authority or your regulatory adviser before filing.
Why one European notification is no longer enough
The European system requires a Responsible Person established in the EU, who notifies the product on the Cosmetic Product Notification Portal before it is placed on the market. The Product Information File and the Cosmetic Product Safety Report sit with that Responsible Person.
After the UK left the EU, Great Britain adopted a parallel regime with its own portal and its own responsible person requirement. The underlying technical standards remain close, because UK cosmetics law derives from the same regulation, but the notification, the address on the label and the enforcement authority are distinct. A product can therefore be fully compliant in the EU and illegally on sale in Great Britain on the same day, which is a risk worth taking seriously given how often EU and UK retailers are supplied from the same warehouse.
| Element | European Union | Great Britain |
|---|---|---|
| Notification portal | The EU portal, submitted by the responsible person | The UK notification service, submitted by the UK responsible person |
| Responsible person | Established in the EU | Established in Great Britain |
| Timing | Before the product is placed on the market | Before the product is placed on the market |
| Technical file | Product Information File including a Cosmetic Product Safety Report | An equivalent technical file held by the UK responsible person |
| Address on the label | The EU responsible person | The UK responsible person |
| Northern Ireland | Follows the European framework | Great Britain only |
Who is the responsible person in each market?
In the European Union the responsible person must be established in the EU. For an overseas brand this normally means appointing an EU-based entity, whether a subsidiary, a distributor acting in that capacity, or a specialist service provider. The responsible person holds the Product Information File, signs off the notification and is the party the authority contacts.
In Great Britain the equivalent role is a UK-based responsible person with an address in Great Britain. The name and address appear on the label. As with the EU, an overseas brand usually appoints an entity rather than setting up a presence itself.
Two practical points cause most of the friction. First, the address printed on the artwork differs between the two markets, so the label is not interchangeable. Second, the responsible person is not a formality; the party named is legally answerable for the safety file, for the notification, and for responding to a market surveillance enquiry. A distributor acting as an informal point of contact without holding the file is not sufficient.
What the EU notification requires
Notification on the EU portal is made before the product is placed on the market, and it is made by the responsible person rather than by the manufacturer. The information required is administrative rather than scientific at the point of submission, which is why brands sometimes assume that a notification equals compliance. It does not.
The notification covers the product identity and category, the responsible person and, where relevant, the manufacturer and the place of manufacture, the frame formulation, the presence of nanomaterials, and substances classified as carcinogenic, mutagenic or toxic to reproduction where they are used within the permitted framework. A frame formulation describes the product by ingredient function and concentration bands rather than by a full quantitative formula, which means the exact percentages are not published.
Critically, notification is a disclosure obligation and not an approval. The substance of compliance is the Product Information File, which is not submitted but must exist and be available to the authority on request. A brand that has notified but cannot produce the file on request is not compliant, and the gap is only discovered at the worst possible moment, which is during a market surveillance enquiry or a retailer audit.
What the UK notification requires
The UK system operates a notification service for products placed on the Great Britain market, and the information required closely mirrors the EU set, which is a help for brands selling in both because much of the source data is the same. The UK responsible person submits it, and the product cannot be placed on the market before the notification is submitted.
The differences that matter in practice are the responsible person details, the address on the label, and the fact that the two notifications are separate filings rather than a single record. Some of the technical annexes and restrictions have diverged slightly since exit, and where the UK has amended its own retained version of the legislation, the difference is real rather than cosmetic. Confirm the current UK restrictions for any ingredient near a permitted limit rather than assuming the EU position applies.
Great Britain and Northern Ireland are not the same market
Northern Ireland follows the European framework for cosmetics, while Great Britain follows the UK framework. For a brand selling into both, the practical result is that Northern Ireland is covered by the EU notification and Great Britain by the UK notification, and the labelling requirements follow the corresponding responsible person.
This creates the specific trap of a "UK" launch that only covers one of the two territories. A brand that notifies on the UK service and ships to Belfast can find itself with a product that is not correctly notified for the market it is in. The safe approach is to decide explicitly which of the two territories each sales channel serves, and to treat the answer as a market-entry decision rather than a labelling footnote.
The documentation that has to exist first
Both notifications depend on a documentation set that the manufacturer provides and the responsible person holds. For a private label brand working with an overseas factory, the following is the practical minimum.
The full qualitative and quantitative formula, including each ingredient at its concentration and its function. The safety assessment for the finished formula, prepared by a suitably qualified assessor, addressing the exposure assumptions for the product type and application site. A method of manufacture description and a statement of compliance with good manufacturing practice, normally evidenced by an ISO 22716 certificate. Proof of the effect claimed, where the product makes a performance claim that must be substantiated. And the data supporting the ingredient declarations, including any nanomaterial content and any restricted substance used within permitted limits.
Two items are frequently missing when a brand first asks. The first is a proper safety assessment for the exact formula being manufactured rather than for a similar one that the factory already sells. The second is the evidence supporting the claims the brand intends to publish. Both are cheap to fix early and expensive to fix late.
Where OEM buyers most often lose time
Four delays recur in almost every cross-border project.
The first is artwork. The responsible person name and address, the nominal content, the batch code position, the date of minimum durability format and the list of ingredients all have to be correct on the finished pack, and any change after printing is expensive. Getting the artwork reviewed against the notification data before the print run is the single highest-value step in the whole process.
The second is the frame formulation. If the brand supplies a full quantitative formula to a notification agent who needs to map it to a frame formulation, the mapping takes time and can reveal that an ingredient is missing a documented function.
The third is the safety assessor's questions. A competent assessor will ask for toxicological justification for unusual ingredients, for stability data, and for the microbiological challenge result, and a factory that has not been asked for these before will take longer to respond.
The fourth is fragrance documentation. If the product contains fragrance, the responsible person needs the allergen breakdown and the composition statement, and fragrance houses can take days to release it. Requesting it at brief stage rather than at artwork stage removes the delay.
What a manufacturer should be able to send you
A factory that regularly supports EU and UK launches should be able to provide the following without a special project charge, because they are part of producing a marketable product rather than optional extras.
A full formula specification with concentrations and functions. Accelerated and real-time stability reports on the finished product in its final packaging. A microbiological challenge test report. A pack compatibility report. An ingredient documentation pack including any restricted substance statements and nanomaterial declarations. A good manufacturing practice certificate. And a fragrance allergen breakdown where applicable.
We supply this documentation in English so that it can be handed directly to a notification agent or a safety assessor without translation, because a translated dossier is one more place for an error to enter the process.
What this means for your launch plan
The realistic sequence for a new product entering both markets is: freeze the formula, freeze the packaging, obtain the documentation set, commission the safety assessment, appoint the responsible persons, prepare the artwork against the notification data, submit both notifications, then release the product for sale. The artwork step depends on the notification data, and the notification depends on the safety assessment, so the chain cannot be compressed by working on the label design first.
Where a brand has a fixed launch date, the useful planning move is to identify the longest dependency, which is usually the safety assessment combined with the fragrance documentation, and to start both before the sample is approved. Samples and paperwork can run in parallel.
Frequently asked questions about cosmetic notification
Does notification mean my product is approved?
No. Notification is a disclosure step, not an authorisation. Compliance rests on the Product Information File and the safety assessment, which must exist and be available to the authority on request.
Can the manufacturer notify on my behalf?
The obligation sits with the responsible person, and the responsible person must be established in the relevant market. A factory in another country cannot hold that role, although it supplies the documentation the responsible person needs.
Do I need separate artwork for the EU and the UK?
Usually yes, because the responsible person name and address differ, and some labelling details differ as well. Budgeting for a second artwork version is more realistic than assuming one label covers both.
Can you provide the documentation needed for notification?
Yes. Formula specifications, stability and challenge test reports, pack compatibility reports, GMP evidence, ingredient documentation and fragrance allergen breakdowns are supplied as part of a standard project.
How long does notification take?
The submission itself is quick once the data is assembled. The time is consumed by the safety assessment, the fragrance documentation and the artwork review, which is why the paperwork should start alongside sampling rather than after it.
Next step: start the paperwork with the sample
If you are launching a skincare or colour cosmetics product in the EU or the UK, send us the format, the target markets and your timeline and we will confirm what the project can supply for your technical dossier, flag any formula decisions that affect the notification, and provide a costed quote. Write to capsulebiotech@163.com, message the right team on WhatsApp: Capsule Series (capsules only) +86 158-7655-5319, Cosmetics Series (serum, hair care, body care, fragrance) +86 158-7655-5319, or use the inquiry form and we will reply within one working day.
Related programmes and guides: amino acid facial cleanser, hydrating soothing repair face cream, and hyaluronic acid face serum softgel capsules.